Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Waxman/Hatch revisions

This article was originally published in The Tan Sheet

Executive Summary

Consumer Healthcare Products Association President Michael Maves, MD, will attend a Dec. 14 meeting with Sen. Orrin Hatch (R-Utah) to discuss possible patent reform revisions. Other trade association heads who will be in attendance include Alan Holmer of the Pharmaceutical Research & Manufacturers of America and Alice Till of the Generic Pharmaceutical Industry Association; consumer organizations are scheduled to meet with Hatch on Jan. 5. Hatch's attention to patent reform issues may have been spurred most recently during the Judiciary Committee's consideration of legislation that would have permitted a patent extension for Schering-Plough's Claritin (loratadine) (1"The Tan Sheet" Nov. 29, In Brief)

You may also be interested in...



Supplement Science, Switch Advocacy Stressed At CHPA Conference

The Consumer Healthcare Products Association plans to pursue a science-driven approach in its dietary supplement agenda, CHPA President Michael Maves, MD, stated.

Supplement Science, Switch Advocacy Stressed At CHPA Conference

The Consumer Healthcare Products Association plans to pursue a science-driven approach in its dietary supplement agenda, CHPA President Michael Maves, MD, stated.

Supplement Science, Switch Advocacy Stressed At CHPA Conference

The Consumer Healthcare Products Association plans to pursue a science-driven approach in its dietary supplement agenda, CHPA President Michael Maves, MD, stated.

Related Content

Topics

UsernamePublicRestriction

Register

PS090686

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel